Blueprint Medicines
BPMC
#2489
Rank
A$8.75 B
Marketcap
$137.01
Share price
1.82%
Change (1 day)
-1.49%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$13.83

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$14.36. In 2022 the company made an earnings per share (EPS) of -$14.61 an increase over its 2021 EPS that were of -$17.16.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$13.83-5.39%
2022-$14.61-14.85%
2021-$17.16-297.13%
2020$8.71-176.3%
2019-$11.4135.19%
2018-$8.4438.82%
2017-$6.0847.35%
2016-$4.139.25%
2015-$3.78-31.35%
2014-$5.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.11-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.42-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.99-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA